UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055604
Receipt number R000063509
Scientific Title Investigation of Endoscopic Thyroidectomy for Thyroid Carcinoma In Tokyo
Date of disclosure of the study information 2024/09/25
Last modified on 2025/09/29 09:13:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of Endoscopic Thyroidectomy for Thyroid Carcinoma In Tokyo

Acronym

Tokyo Endoscopic Thyroidectomy Study (TETS)

Scientific Title

Investigation of Endoscopic Thyroidectomy for Thyroid Carcinoma In Tokyo

Scientific Title:Acronym

Tokyo Endoscopic Thyroidectomy Study (TETS)

Region

Japan


Condition

Condition

Thyroid carcinoma

Classification by specialty

Endocrine surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the trends and outcomes of endoscopic thyroidectomy for thyroid carcinoma, targeting cases registered in the Tokyo Cancer Registry, including those before and after the procedure became covered by insurance in 2018. A comparison with open surgery will also be conducted.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Overall survival (OS)

Key secondary outcomes

Disease-specific survival, 90-day and 180-day mortalities from diagnosis, transition in endoscopic eligibility rates, and evaluation of factors influencing the choice of endoscopic surgery.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients registered in the Tokyo Cancer Registry between 2012 and 2020, with ICD-O3 code C739 and excluding ICD-10 code C73.

Key exclusion criteria

Histopathological diagnosis other than papillary or follicular thyroid carcinoma, and cases where the type of surgery (endoscopic or open) is unclear.

Target sample size

10000


Research contact person

Name of lead principal investigator

1st name Yoshiyuki
Middle name
Last name Saito

Organization

Ito hospital

Division name

Department of Surgery

Zip code

160-8582

Address

4-3-6 Jinguumae, Shibuya-ku, Tokyo, Japan

TEL

+81-3-3402-7411

Email

y-saito@ito-hospital.jp


Public contact

Name of contact person

1st name Yoshiyuki
Middle name
Last name Saito

Organization

Ito hospital

Division name

Department of Surgery

Zip code

160-8582

Address

4-3-6 Jinguumae, Shibuya-ku, Tokyo, Japan

TEL

+81-3-3402-7411

Homepage URL


Email

y-saito@ito-hospital.jp


Sponsor or person

Institute

Ito hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ito Hospital Institutional Review Board

Address

4-3-6 Jinguumae, Shibuya-ku, Tokyo, Japan

Tel

+81-3-3402-7411

Email

k-sugino@ito-hospital.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 09 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

11989

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 11 Month 18 Day

Date of IRB

2024 Year 11 Month 27 Day

Anticipated trial start date

2024 Year 10 Month 01 Day

Last follow-up date

2024 Year 10 Month 01 Day

Date of closure to data entry

2024 Year 12 Month 14 Day

Date trial data considered complete

2024 Year 12 Month 14 Day

Date analysis concluded



Other

Other related information

Objective:
To investigate the trends and outcomes of endoscopic surgery for thyroid carcinoma using data from the Tokyo Cancer Registry.
Design:
Retrospective observational study using data from the Tokyo Cancer Registry.
Setting:
This study utilizes the Tokyo Cancer Registry data. Data extraction and analysis will be conducted ensuring confidentiality and compliance with all applicable regulations.
Participants:
Patients registered in the Tokyo Cancer Registry between 2012 and 2020 who underwent either endoscopic or open thyroid surgery.
Main Outcome and Measure:
The primary outcome is overall survival (OS). Secondary outcomes include disease-specific survival, 90-day and 180-day mortalities from diagnosis, the transition of endoscopic eligibility rates, and an evaluation of factors influencing the choice of endoscopic surgery.


Management information

Registered date

2024 Year 09 Month 24 Day

Last modified on

2025 Year 09 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063509